Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00502
Species: Homo sapiens
Position : chr8:128744932-128746104
Year: 2025
Title: Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  41266362
MONDO: MONDO:0008315
Tissue: Prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: MDA PCa 2B cells
CVCL ID: CVCL_4740
Cell Type: prostate carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay
High Throughput Method: ChIP-seq, ATAC-seq, RNA-seq
Low Throughput Method: Luciferase reporter assay, ChIP-RT-qPCR, RT-RT-qPCR
About Target Gene
Target gene : NDRG1
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Silenced
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00419 chr8:128740000-128790000 Colon colorectal carcinoma cell colorectal carcinoma
E_00112 chr8:128745000-128752600 Epithelium breast epithelial cell Cancer
E_00650 chr8:128745000-128745100 Colon colorectal carcinoma cell colorectal cancer
Expression of Target Genes for the Enhancer